[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350715-105":59,"doc-detail-350715-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","crosstalk-between-m6a-modification-and-metabolic-reprogramming-in-colorectal-cancer-from-the-immune-microenvironment-to-clinical-applications","Crosstalk between m6A modification and metabolic reprogramming in colorectal cancer: from the immune microenvironment to clinical applications","","N6-methyladenosine (m6A) modification, the most common mRNA epigenetic alteration, reshapes colorectal cancer (CRC) metabolism and the tumor microenvironment (TME) by dynamically regulating RNA metabolic processes. Evidence indicates m6A promotes an immunosuppressive TME: it supports CRC progression by tuning glucose, lipid, and amino acid metabolism while restraining antitumor immune cells and activating multiple tumor immunosuppressive populations. This review integrates molecular mechanisms, metabolic networks, and immune crosstalk, and evaluates therapeutic potential for targeting m6A and metabolic pathways.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/crosstalk-between-m6a-modification-and-metabolic-reprogramming-in-colorectal-cancer-from-the-immune-microenvironment-to-clinical-applications/350715/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/crosstalk-between-m6a-modification-and-metabolic-reprogramming-in-colorectal-cancer-from-the-immune-microenvironment-to-clinical-applications/350715.png","ImageObject",300,407,{"name":92,"@type":93},"dhado","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the role of m6A modification in colorectal cancer?","Question",{"text":112,"@type":113},"m6A modification regulates RNA metabolic processes that impact CRC metabolism and the tumor microenvironment (TME). It can promote CRC progression by coordinating nutrient metabolism and immune evasion.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does m6A affect metabolic reprogramming in CRC?",{"text":117,"@type":113},"The document describes metabolic changes including enhanced glycolysis, increased glucose uptake, altered lipid and protein synthesis, and shifts in amino acid uptake and catabolism. It links these shifts to m6A-driven regulation of glucose, lipid, and amino acid metabolism.",{"name":119,"@type":110,"acceptedAnswer":120},"How does m6A-related metabolic reprogramming influence the immune microenvironment?",{"text":121,"@type":113},"m6A-driven metabolic regulation is associated with an immunosuppressive TME. It inhibits antitumor immune cell activity (e.g., T cells, NK cells, macrophages) while activating multiple immunosuppressive cell types such as TAMs, MDSCs, Tregs, and CAF-related components.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350715,1790109073,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","TYPE Review  \nPUBLISHED 12 August 2026  \nDOI 10.3389/fimmu.2026.1911067  \nOPEN ACCESS  \nEDITED BY  \nGaia Codolo,  \nUniversity of Padua, Italy  \nREVIEWED BY  \nChen Xue,  \nZhejiang University, China Yuxin Tong,  \nChongqing Medical University, China  \n*CORRESPONDENCE  \nHongjian Gao  \n[gaohj1970@126.com](gaohj1970@126.com)[ ](gaohj1970@126.com)Hexue Yuan  \n[yuanhexue@163.com](yuanhexue@163.com)  \n†These authors have contributed equally to this work  \nRECEIVED 16 June 2026  \nACCEPTED 28 July 2026  \nPUBLISHED 12 August 2026  \nCITATION  \nZhao L, Yin Z, Ji C, Wu Y, Gao H and Yuan H (2026) Crosstalk between m6A modiﬁcation and metabolic reprogramming in colorectal cancer:  \nfrom the immune microenvironment to clinical applications.  \nFront. Immunol. 17:1911067 .  \ndoi: 10.3389/fimmu.2026.1911067  \nCOPYRIGHT  \n© 2026 Zhao, Yin, Ji, Wu, Gao and Yuan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) .  \nThe use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nCrosstalk between m 6A modiﬁcation and metabolic reprogramming in colorectal cancer: from the immune microenvironment to clinical applications  \nLiang Zhao 1†, Zhitao Yin 1†, Chenchun Ji 1, Yan Wu 1, Hongjian Gao 2* and Hexue Yuan 1*  \n1 Department of Colorectal Anal surgery, Shenyang Coloproctology Hospital, Shenyang, Liaoning, China, 2 Department of Gastrointestinal Oncology Surgery, Shenyang Coloproctology Hospital, Shenyang, Liaoning, China  \nN6-methyladenosine (m6A) modiﬁcation is the most common epigenetic alteration in eukaryotic mRNA, signiﬁcantly impacting metabolic reprogramming and the tumor microenvironment (TME) of colorectal cancer (CRC) by dynamically regulating RNA metabolic processes. Recent studies indicate that m6A modiﬁcation interacts with CRC metabolic reprogramming, fostering an immunosuppressive TME. Speciﬁcally, m6A modiﬁcation promotes CRC progression by regulating glucose, lipid, and amino acid metabolism while inhibiting the activity of antitumor immune cells (such as T cells, natural killer cells, and macrophages) and activating tumor immunosuppressive cells (including tumor-associated macrophages, myeloid-derived suppressor cells, regulatory T cells, tumor-associated neutrophils, and cancer-associated ﬁbroblasts) . This article systematically reviews the molecular mechanisms through which m6A modiﬁcation drives the malignant progression of CRC via metabolic regulation, elucidates the metabolic network involving m6A modiﬁcation and its role in shaping TME, and discusses the clinical potential of targeting m6A modiﬁcation and/or metabolic pathways, offering novel research avenues for CRC treatment.  \nKEYWORDS  \nCRC, gut microbiota, m6A, metabolic reprogramming, TME  \n1 Introduction  \nColorectal cancer (CRC) is the third most prevalent malignant tumor globally, with a 5-year survival rate of \u003C 15% for metastatic cases (1–3) . Despite signiﬁcant advancements in diagnostic and therapeutic techniques in recent years, the heterogeneity and metabolic plasticity ofCRC continue to pose therapeutic challenges. Traditionally, oncogene activation and tumor suppressor gene inactivation have been considered the primary drivers of CRC development. However, recent research has highlighted metabolic reprogramming and immune evasion as crucial hallmarks of tumors (4), with further studies demonstrating that  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nmetabolic reprogramming not only promotes tumor progression but also contributes to the formation of an immunosuppressive tumor microenvironment (TME) (5) .  \nMetabolic alterations in CRC are characterized by enhanced glycolysis, increased glucose uptake and consumpti","cbCaifPIHPEcCDwg","https://ap.wps.com/l/cbCaifPIHPEcCDwg","pdf",1790200,17,"English","# 1 Introduction\n# KEYWORDS\n# 2 Crosstalk between m6A modification and metabolic reprogramming in CRC","[{\"question\":\"What is the role of m6A modification in colorectal cancer?\",\"answer\":\"m6A modification regulates RNA metabolic processes that impact CRC metabolism and the tumor microenvironment (TME). It can promote CRC progression by coordinating nutrient metabolism and immune evasion.\"},{\"question\":\"How does m6A affect metabolic reprogramming in CRC?\",\"answer\":\"The document describes metabolic changes including enhanced glycolysis, increased glucose uptake, altered lipid and protein synthesis, and shifts in amino acid uptake and catabolism. It links these shifts to m6A-driven regulation of glucose, lipid, and amino acid metabolism.\"},{\"question\":\"How does m6A-related metabolic reprogramming influence the immune microenvironment?\",\"answer\":\"m6A-driven metabolic regulation is associated with an immunosuppressive TME. It inhibits antitumor immune cell activity (e.g., T cells, NK cells, macrophages) while activating multiple immunosuppressive cell types such as TAMs, MDSCs, Tregs, and CAF-related components.\"}]","Crosstalk between m6A modification and metabolic reprogramming in colorectal cancer: from the immune microenvironment to clinical applications | PDF",1790090714,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56c5b87d75584f983ca9465b8c089a3a.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d89192c53437549a2ba461255efb9877.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1dd089e161a4dbd524febe5a2ca8d9ef.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/234c94c57d462a25e589db5788a85070.webp",980,1385]